Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Nonmelanoma skin cancer | Synapse

January 1, 2012Open Access

Nonmelanoma skin cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Nonmelanoma skin cancer (NMSC) represents the most common form of cancer in Caucasians, with continuing increase in incidence worldwide. Basal cell carcinoma (BCC) accounts for 75% of cases of NMSC, and squamous cell carcinoma (SCC) accounts for the remaining majority of NMSC cases. Whilst metastasis from BCC is extremely rare, metastasis from high-risk SCC may be fatal. In this article, we review the aetiology, diagnosis and management of NMSC.

Read Full Paperexternally

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Samarasinghe et al. (Sun,) studied this question.

synapsesocial.com/papers/69db1ddc1e19c8ae088365ed https://doi.org/https://doi.org/10.4103/0974-2077.94323

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Imiquimod: a review of basal cell carcinoma treatments.2008 · 20 citations
2Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.2010 · 76 citations
3Guidelines for the management of basal cell carcinoma1999 · 341 citations
4Two‐year interim results from a 5‐year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks2006 · 41 citations
5Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.2008 · 248 citations